Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Obalon Therapeutics Inc (OBLN)

Obalon Therapeutics Inc (OBLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Obalon Therapeutics Inc 5421 Avenida Encinas Suite F Carlsbad CA 92008 USA

P: 844-362-2566

Description:

Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 9,195
Shares Outstanding, K 5,573
Annual Sales, $ 9,100 K
Annual Net Income, $ -37,380 K
Last Quarter Sales, $ 330 K
Last Quarter Net Income, $ -3,710 K
60-Month Beta -4.87
% of Insider Shareholders 14.30%
% of Institutional Shareholders 38.24%
Float, K 4,776
% Float 85.70%

Growth:

1-Year Return -91.51%
3-Year Return -98.54%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/08/19
Earnings Per Share ttm -10.61
EPS Growth vs. Prev Qtr 30.56%
EPS Growth vs. Prev Year -143.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 07/25/19

OBLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.16
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -294.72
Return-on-Assets (Before Tax) -100.74
Profit Margin % -410.77
Net Margin % N/A
Debt/Equity 0.09
Price/Sales 1.03
Price/Cash Flow N/A
Price/Book 0.76
Book Value/Share 2.61
Interest Coverage -161.52
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar